Goldman Sachs’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.9M | Sell |
|
|||||
|
2025
Q1 | $43.7M | Buy |
|
|||||
|
2024
Q4 | $17.5M | Sell |
|
|||||
|
2024
Q3 | $16.2M | Sell |
|
|||||
|
2024
Q2 | $20.3M | Buy |
|
|||||
|
2024
Q1 | $22.4M | Sell |
|
|||||
|
2023
Q4 | $29.3M | Sell |
|
|||||
|
2023
Q3 | $39.1M | Buy |
|
|||||
|
2023
Q2 | $34M | Buy |
|
|||||
|
2023
Q1 | $40M | Sell |
|
|||||
|
2022
Q4 | $70.7M | Sell |
|
|||||
|
2022
Q3 | $102M | Sell |
|
|||||
|
2022
Q2 | $152M | Sell |
|
|||||
|
2022
Q1 | $165M | Sell |
|
|||||
|
2021
Q4 | $167M | Buy |
|
|||||
|
2021
Q3 | $23.1M | Sell |
|
|||||
|
2021
Q2 | $54.4M | Sell |
|
|||||
|
2021
Q1 | $87.8M | Sell |
|
|||||
|
2020
Q4 | $95.7M | Buy |
|
|||||
|
2020
Q3 | $49M | Sell |
|
|||||
|
2020
Q2 | $62.9M | Sell |
|
|||||
|
2020
Q1 | $64.4M | Sell |
|
|||||
|
2019
Q4 | $106M | Buy |
|
|||||
|
2019
Q3 | $84.6M | Buy |
|
|||||
|
2019
Q2 | $55.2M | Sell |
|
|||||
|
2019
Q1 | $87M | Buy |
|
|||||
|
2018
Q4 | $51.2M | Sell |
|
|||||
|
2018
Q3 | $86.7M | Buy |
|
|||||
|
2018
Q2 | $81.4M | Sell |
|
|||||
|
2018
Q1 | $111M | Sell |
|
|||||
|
2017
Q4 | $102M | Buy |
|
|||||
|
2017
Q3 | $85.5M | Buy |
|
|||||
|
2017
Q2 | $34.4M | Sell |
|
|||||
|
2017
Q1 | $46.5M | Sell |
|
|||||
|
2016
Q4 | $40.6M | Sell |
|
|||||
|
2016
Q3 | $85.5M | Buy |
|
|||||
|
2016
Q2 | $84.2M | Buy |
|
|||||
|
2016
Q1 | $29.2M | Buy |
|
|||||
|
2015
Q4 | $24.3M | Sell |
|
|||||
|
2015
Q3 | $47.4M | Sell |
|
|||||
|
2015
Q2 | $68.5M | Buy |
|
|||||
|
2015
Q1 | $24.6M | Buy |
|
|||||
|
2014
Q4 | $7.57M | Sell |
|
|||||
|
2014
Q3 | $7.47M | Sell |
|
|||||
|
2014
Q2 | $17.5M | Sell |
|
|||||
|
2014
Q1 | $19.3M | Sell |
|
|||||
|
2013
Q4 | $29.4M | Buy |
|
|||||
|
2013
Q3 | $14.8M | Buy |
|
|||||
|
2013
Q2 | $5.8M | Buy |
|